New data in the diagnosis and prognosis of multiple myeloma

Relapse and retreatment of multiple myeloma

Mutiple myeloma treatment in the non-transplant setting

Expert Panel: Anaemia, neutropenia, thrombocytopenia and cancer

ASCO GU: Current thinking in mCRPC

Overtreatment of low risk prostate cancer: incidence in USA, cost, complications and implications

Prediction of relapse in stage I nonseminomatous germ cell tumors by CXCL12

Chemo-radiotherapy for bladder cancer

TIVO 1 study shows tivozanib an option for renal cell carcinoma

Pelvic radiotherapy and androgen blockade for high risk prostate cancer

Gleason upgrading with time in a large, active surveillance cohort with long-term follow-up

Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancer